Skip to content
Search

Latest Stories

UK government launches new suicide surveillance system

UK government launches new suicide surveillance system

Female deaths by suicide are increasing at a higher rate than male deaths in England  

The Department of Health and Social Care (DHSC) on Thursday (30th November) announced the launch of a new suicide surveillance system, bolstering its efforts to tackle emerging methods of suicide and clamp down on those seeking to sell dangerous products to vulnerable people.


For now, the DHSC will work with the National Police Chiefs’ Council to gather near to real-time data from across the country on deaths by suspected suicide by gender, age group and method.

The data will be obtained from individual police forces in England and the government will get it within three months of a suspected suicide, the DHSC said in its release.

Previously, the only suicide data available at a national level was provided by the Office for National Statistics (ONS), but it could take up to 2 years for the official ONS data to come through.

Mental Health Minister Maria Caulfield said: “Every suicide is a tragedy and has a devastating, enduring impact on families and communities, but we are working at pace to reduce the number of suicides, support those reaching the lowest point and tackle emerging methods and harmful online material.

“The national suspected suicide surveillance system is vital to achieving this, and will provide important near real-time data so we can spot anomalies in age, gender and method more quickly and take the necessary action to save lives,” she added.

Female deaths by suicide are increasing at a higher rate than male deaths in the country, the health department informed, stressing the importance of identifying such trends as early as possible so that preventative measures can be taken to save lives.

The government will publish a monthly report on the new datasets, which will help indicate any change in suicide trends early, as well support the future rollout of a national alert system to notify schools, universities and charities of emerging methods of suicide and risks.

Launching the national suicide prevention strategy earlier this year, the UK government had pledged to reduce England’s suicide rate within two and a half years.

“Suicide has a devastating impact, we must do all we can to protect people and reduce preventable death,” said National Police Chiefs’ Council lead for Suicide Prevention, Assistant Chief Constable Charlie Doyle

He welcomed the government’s announcement and ensured to work with partners to reduce suicide.

Encourage or assisting suicide is an offence under the Suicide Act in the UK, where the Online Safety Act 2023 also ensures social media companies proactively prevent people from seeing content that encourages or assists suicide.

Data for England for the 15 months to August 2023 showed an obvious change in trend in overall suspected suicide rates over the period, but the country saw a reduction in suspected suicide rates in the most recent months.

Measures to support mental health

An additional investment of £2.3 billion a year is being made into mental health services to help two million more people access NHS-funded mental health support by 2024, the DHSC informed.

Furthermore, a £10 million fund was recently launched for the voluntary sector in England to carry out crucial work to save lives until 2025.

The UK government is also investing £150 million up to April 2025 to better support people experiencing, or at risk of experiencing, mental health crises.

The investment will be used to support the roll out of mental health ambulances and delivery of over 160 projects - including alternatives to A&E - to ensure people receive specialist care in appropriate spaces and help ease pressure on the NHS.

Mental health workforce is growing continuously and helping cut waiting lists, thanks to the NHS Long Term Workforce Plan, which aims to grow the mental health workforce by 73 per cent by 2036 to 2037.

Help and support is provided for anyone experiencing suicidal thoughts on the NHS website.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less